Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Drug Repurposing Is Revitalizing the Pharma Industry

Posted on October 16th, 2018 by in Pharma R&D

The average expense of bringing a new drug to market has increased by more than 200 percent since the 1990s, with development costs regularly running into the billions. As pharma revenues continue to sink below the costs of creating commercially viable drugs, a growing number of developers are exploring a different approach: seeking out additional monetizable uses for drugs to which they already own intellectual property rights. (more…)

Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better

Posted on October 16th, 2018 by in Pharma R&D

Genetic testing has become a big hit with consumers. Companies like Ancestry.com and 23andMe flood the airwaves with commercials about the joy of using DNA testing to find out about your heritage. But another reason genetic testing is attracting consumers is because it also can tell people about some of their genetic health risks. (more…)

The Delicate Balance of Drug Risks vs. Benefits

Posted on October 16th, 2018 by in Pharma R&D

For many people, taking medication is a regular part of their daily routine, and these medicines are relied upon to treat disease and improve health.  The benefits of medicines are the helpful effects you get when you use them, such as the lowering blood pressure, curing infection, or relieving pain. (more…)

  1. 1
  2. 3
  3. 4
  4. 5